Strategic partnerships Growth through distribution partnerships is already happening (Matriks Biotek, Genetic Analysis AS). Sales teams should target additional North American and European distributors and academic/clinical lab networks to expand reach for antibody and ELISA kits.

Product expansion Recent launches include monoclonal IHC antibodies and various ELISA kits (Anti-tTG sIgA/IgA, intact FGF23). Upsell opportunities exist by cross-selling these new lines to existing customers and converting interest into bundled assay solutions.

Market positioning Small team size with high service focus and strong repeat business signals a premium, relationship-driven sales approach. Emphasize reliability, support, and quick information as differentiators to win competitor switchovers.

Digital footprint Website upgrades and tech stack (WordPress, Tidio, reCAPTCHA) indicate active online presence and customer engagement. Leverage targeted content, live chat, and email campaigns to capture inquiries from researchers and clinical labs.

Financial foothold Annual revenue in the low-to-mid single-digit millions suggests opportunity to scale through expanded product lines and channel sales. Propose tiered pricing, volume discounts, and partner-friendly terms to accelerate growth.